SCHEMBL25975808

SCHEMBL25975808

Cc1ccc2ncn(I)c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 2/20 0.43
POLB P06746 1/20 0.42
TRPA1 O75762 1/20 0.42
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ELANE P08246 1/20 0.40
HCAR1 Q9BXC0 2/20 0.39
IP6K1 Q92551 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HTT P42858 2/20 0.39
MAPK1 P28482 1/20 0.39
DDR1 Q08345 1/20 0.39
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7600132 0.81 L3MBTL1 (0.60) PARP1SMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL29607244 0.81 L3MBTL1 (0.60) PARP1SMN1; SMN2TP53ALDH1A1L3MBTL1
SCHEMBL24072199 0.79 PARP1 (0.51) PARP1SMN1; SMN2TP53POLBTRPA1
SCHEMBL12049203 0.77 TP53 (0.53) PARP1SMN1; SMN2TP53TRPA1ALDH1A1
SCHEMBL23915838 0.76 FGFR1 (0.43) SMN1; SMN2POLBALDH1A1L3MBTL1HCAR1
SCHEMBL31103600 0.74 FGFR1 (0.59) SMN1; SMN2TP53POLBHCAR1NPC1
SCHEMBL10084695 0.74 TP53 (0.51) SMN1; SMN2TP53POLBTRPA1ALDH1A1
SCHEMBL16181504 0.74 KDM4E (0.54) SMN1; SMN2POLBKDM4EHTTNPC1
SCHEMBL10085099 0.72 HDAC6 (0.61) SMN1; SMN2TP53POLBTRPA1ALDH1A1
SCHEMBL30704943 0.71 POLB (0.48) PARP1SMN1; SMN2TP53POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed